NCT05421962View on ClinicalTrials.gov

Analgosedation for Elective Colonoscopy

PHASE1CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

December 15, 2021

Study Completion Date

December 15, 2021

Conditions
PainSide Effect
Interventions
DRUG

Ketamine

Ninety patients were included and randomized to either fentanyl-propofol (Group FP, n: 30), ketamine-propofol (Group KP, n: 30) or propofol-control group (Group C, n: 30). Group FP patients received fentanyl and propofol, Group KP received ketamine and propofol and Group C, propofol.

Trial Locations (1)

72000

Cantonal Hospital, Zenica

All Listed Sponsors
lead

Cantonal Hospital Zenica

OTHER

NCT05421962 - Analgosedation for Elective Colonoscopy | Biotech Hunter | Biotech Hunter